StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics total assets

Total assets on the balance sheet at the end of each period.

Bionano Genomics's total assets was $47.59M at Jun 30, 2026. For fiscal 2025 it was $73.58M, down 4.0% from the year before. The highest annual figure on record is $377.10M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$73.58M-4.0%
FY2024Dec 31, 2024$76.67M-64.2%
FY2023Dec 31, 2023$214.40M-30.3%
FY2022Dec 31, 2022$307.50M-18.5%
FY2021Dec 31, 2021$377.10M+523.8%
FY2020Dec 31, 2020$60.45M+100.1%
FY2019Dec 31, 2019$30.21M+21.8%
FY2018Dec 31, 2018$24.80M+144.5%
FY2017Dec 31, 2017$10.15M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$47.59M-37.4%
Q1 FY2026Mar 31, 2026$64.80M-17.4%
Q4 FY2025Dec 31, 2025$73.58M-4.0%
Q3 FY2025Sep 30, 2025$79.06M-9.5%
Q2 FY2025Jun 30, 2025$76.01M-41.2%
Q1 FY2025Mar 31, 2025$78.41M-50.4%
Q4 FY2024Dec 31, 2024$76.67M-64.2%
Q3 FY2024Sep 30, 2024$87.36M-52.0%
Q2 FY2024Jun 30, 2024$129.36M-52.3%
Q1 FY2024Mar 31, 2024$158.00M-45.9%
Q4 FY2023Dec 31, 2023$214.40M-30.3%
Q3 FY2023Sep 30, 2023$181.90M-43.8%
Q2 FY2023Jun 30, 2023$271.38M-15.6%
Q1 FY2023Mar 31, 2023$292.15M-16.1%
Q4 FY2022Dec 31, 2022$307.50M-18.5%
Q3 FY2022Sep 30, 2022$323.70M-10.0%
Q2 FY2022Jun 30, 2022$321.55M-9.9%
Q1 FY2022Mar 31, 2022$348.21M-9.5%
Q4 FY2021Dec 31, 2021$377.10M+523.8%
Q3 FY2021Sep 30, 2021$359.66M+768.8%
Q2 FY2021Jun 30, 2021$356.81M+1211.6%
Q1 FY2021Mar 31, 2021$384.86M+1914.8%
Q4 FY2020Dec 31, 2020$60.45M+100.1%
Q3 FY2020Sep 30, 2020$41.40M+115.5%
Q2 FY2020Jun 30, 2020$27.20M+7.9%
Q1 FY2020Mar 31, 2020$19.10M-35.4%
Q4 FY2019Dec 31, 2019$30.21M+21.8%
Q3 FY2019Sep 30, 2019$19.21M-37.4%
Q2 FY2019Jun 30, 2019$25.21M+148.5%
Q1 FY2019Mar 31, 2019$29.55M–
Q4 FY2018Dec 31, 2018$24.80M–
Q3 FY2018Sep 30, 2018$30.67M–
Q4 FY2017Dec 31, 2017$10.15M–

More Bionano Genomics figures

See a number that looks wrong?